Patents by Inventor Yitzhak Lerner

Yitzhak Lerner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030203878
    Abstract: The present invention provides a compacted pharmaceutical composition for oral administration to a patient which expands upon contact with gastric fluid to retain a dosage form in the patient's stomach for an extended period of time, the formulation comprising a non-hydrated hydrogel, a superdisintegrant and tannic acid. The present invention further provides a pharmaceutical dosage form containing an active ingredient, and the compacted pharmaceutical composition.
    Type: Application
    Filed: April 22, 2003
    Publication date: October 30, 2003
    Inventors: Moshe Flashner-Barak, Vered Rosenberger, Mazal Dahan, Yitzhak Lerner
  • Patent number: 6476006
    Abstract: The present invention provides compacted pharmaceutical composition for oral administration to a patient which expands upon contact with gastric fluid to retain a dosage form in the patient's stomach for an extended period of time, the formulation comprising a non-hydrated hydrogel, a superdisintegrant and tannic acid. The present invention further provides a pharmaceutical dosage form containing an active ingredient, and the compacted pharmaceutical composition. The invention further provides a dosage form suitable for delivering a therapeutic bis-phosphonate such as alendronate to the stomach of a patient over and extended period.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: November 5, 2002
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Moshe Flashner-Barak, Vered Rosenberger, Mazal Dahan, Yitzhak Lerner
  • Publication number: 20020015733
    Abstract: The present invention provides compacted pharmaceutical composition for oral administration to a patient which expands upon contact with gastric fluid to retain a dosage form in the patient's stomach for an extended period of time, the formulation comprising a non-hydrated hydrogel, a superdisintegrant and tannic acid. The present invention further provides a pharmaceutical dosage form containing an active ingredient, and the compacted pharmaceutical composition.
    Type: Application
    Filed: January 26, 2001
    Publication date: February 7, 2002
    Inventors: Moshe Flashner-Barak, Vered Rosenberger, Mazal Dahan, Yitzhak Lerner